about
Genomic analysis identifies association of Fusobacterium with colorectal carcinomaFusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentHuman genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon responseThe TPR-containing domain within Est1 homologs exhibits species-specific roles in telomerase interaction and telomere length homeostasisThe treatment-naive microbiome in new-onset Crohn's diseaseMicrobes and inflammation in colorectal cancer.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.An integrative view of microbiome-host interactions in inflammatory bowel diseasesFusobacterium nucleatum and T Cells in Colorectal Carcinoma.Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans.Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel diseasePrognostically relevant gene signatures of high-grade serous ovarian carcinoma.A Microbiome Foundation for the Study of Crohn's Disease.Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease.Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Keystone microbiome meeting 2012: a mountain top experience.Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing.Aether: leveraging linear programming for optimal cloud computing in genomics.Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites.Gut Microbiota: Small Molecules Modulate Host Cellular Functions.The Crohn's disease polymorphism, T300A, alters the gut microbiota and enhances the local Th1/Th17 responseVariation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in HumansA perfect storm: Genetics and anticommensal antibodies shore up type 1 diabetesFusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability StatusBacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and SymbiosisPredictive metabolomic profiling of microbial communities using amplicon or metagenomic sequencesThe Landscape of Genetic Content in the Gut and Oral Human MicrobiomeMeta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolismUnderstanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United StatesCoproID predicts the source of coprolites and paleofeces using microbiome composition and host DNA contentA systematic machine learning and data type comparison yields metagenomic predictors of infant age, sex, breastfeeding, antibiotic usage, country of origin, and delivery type
P50
Q24603176-22048946-A15E-4984-9AF1-0424CB4AD343Q28296759-7C9AE0FB-6079-44C5-803C-98A21061D0A1Q28540195-F6B35DD3-69A8-46BF-ACAB-45F1329F0EAFQ28975759-C0BC6DFD-D184-4474-AD41-72CE8410CA8EQ33762817-E7988D7B-6A19-4EC5-B804-238A6D5C000CQ35159073-27B53766-A55F-4234-A1DF-20A46EE20ABBQ35557877-A4D8B5DA-CE69-4924-BD9B-C478FDE7CE99Q35631737-5ADF0B63-D3D1-47BC-ABA3-549F627DE800Q35956384-EA4B4658-F4E4-461D-8B6D-1367BD0814DCQ36004640-90F4DCC9-6993-47E3-9D26-55398368D266Q36076691-AE94CFC4-F433-47EB-9769-00132B7433A1Q36497294-0ECABAC0-AF8E-4852-A3BB-54E394CCF4B5Q38748011-BEDC3612-6ED3-4591-8352-BB92294B9997Q38997272-8C9D75DC-1E27-4B15-BCA1-86331501F4B6Q39037480-6249DA3B-8694-467B-88DC-8FAF4CF9192EQ39217446-6F3DF339-6839-45EA-8BE0-AD57B63E80F9Q40127622-9D0B66B0-CD58-459F-A52F-60F0DDA3390DQ40603067-A4720B39-FC45-4F25-9493-723732667838Q45969815-D167CECA-0213-4E68-BC99-29DC94C2AA81Q47222918-EA6EA527-4CDA-423F-833A-0A83D66189DCQ47302178-56A14A59-3AB3-401B-9782-0474977C0652Q52655810-4A158D3A-A4EF-49B0-877C-F27DCA6C5554Q52775114-25DC4559-E1EB-4BFD-BD6A-DC4EB38FDAFCQ61445383-72337461-4C58-41CB-BEEA-E609CF7BE63DQ89361807-D2B9D2D2-52DE-4C5A-873C-D318E05FD8F4Q91311698-3A904CB1-9B04-44EF-9D14-14F97DF6AC6CQ91517890-149DA712-EF16-47DF-B078-22DDA87E56A5Q91884788-3D16386F-C8EE-42EB-BDD2-3F900E44F467Q91968027-718C8546-DF2C-4B7C-95D2-A23B354625F5Q92639511-1AF6C1C2-CAAA-4B45-9270-67CF8488A981Q93001470-F48F6A0E-D211-4637-A0B1-32AF4B379775Q93178009-4CA9D633-AC5E-4CD0-80A3-C6A4D6B17485Q93240669-6AD713D5-A925-4B75-B374-3CD5DE92599EQ94553085-C07A2AA2-AD3F-4EBC-A1CD-52980F5C3DF3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aleksandar D Kostic
@ast
Aleksandar D Kostic
@en
Aleksandar D Kostic
@es
Aleksandar D Kostic
@nl
type
label
Aleksandar D Kostic
@ast
Aleksandar D Kostic
@en
Aleksandar D Kostic
@es
Aleksandar D Kostic
@nl
prefLabel
Aleksandar D Kostic
@ast
Aleksandar D Kostic
@en
Aleksandar D Kostic
@es
Aleksandar D Kostic
@nl
P106
P108
P1153
38761695800
P31
P496
0000-0002-0837-4360